Ofra Sarid‐Segal

1.7k total citations
27 papers, 1.3k citations indexed

About

Ofra Sarid‐Segal is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Ofra Sarid‐Segal has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 8 papers in Psychiatry and Mental health and 6 papers in Pharmacology. Recurrent topics in Ofra Sarid‐Segal's work include Neurotransmitter Receptor Influence on Behavior (11 papers), Substance Abuse Treatment and Outcomes (6 papers) and Treatment of Major Depression (5 papers). Ofra Sarid‐Segal is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (11 papers), Substance Abuse Treatment and Outcomes (6 papers) and Treatment of Major Depression (5 papers). Ofra Sarid‐Segal collaborates with scholars based in United States, South Korea and Ethiopia. Ofra Sarid‐Segal's co-authors include Domenic A. Ciraulo, Chris C. Streeter, Clifford M. Knapp, Perry F. Renshaw, Deborah Yurgelun‐Todd, Maryam Afshar, Marc J. Kaufman, K.K. Midha, Enrico Amico and Eric Devine and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Neuropsychopharmacology.

In The Last Decade

Ofra Sarid‐Segal

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ofra Sarid‐Segal United States 19 601 320 306 282 217 27 1.3k
John Krystal United States 20 853 1.4× 334 1.0× 380 1.2× 338 1.2× 430 2.0× 34 2.0k
Robert Malcolm United States 15 464 0.8× 257 0.8× 226 0.7× 345 1.2× 141 0.6× 24 1.4k
Clifford M. Knapp United States 22 773 1.3× 193 0.6× 183 0.6× 269 1.0× 203 0.9× 47 1.5k
Jesse J. Suh United States 16 424 0.7× 130 0.4× 258 0.8× 356 1.3× 144 0.7× 25 1.2k
Bernhard Croissant Germany 17 382 0.6× 136 0.4× 379 1.2× 175 0.6× 115 0.5× 35 1.1k
Elinore McCance United States 11 1.1k 1.9× 583 1.8× 389 1.3× 322 1.1× 278 1.3× 13 1.9k
Marc Branchey United States 25 517 0.9× 334 1.0× 150 0.5× 322 1.1× 124 0.6× 59 1.7k
Laure Buydens‐Branchey United States 21 453 0.8× 182 0.6× 297 1.0× 105 0.4× 99 0.5× 37 1.3k
Lutz G. Schmidt Germany 26 1.0k 1.7× 255 0.8× 357 1.2× 239 0.8× 252 1.2× 42 1.8k
Ari D. Kalechstein United States 26 1.0k 1.7× 529 1.7× 420 1.4× 484 1.7× 337 1.6× 51 2.0k

Countries citing papers authored by Ofra Sarid‐Segal

Since Specialization
Citations

This map shows the geographic impact of Ofra Sarid‐Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofra Sarid‐Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofra Sarid‐Segal more than expected).

Fields of papers citing papers by Ofra Sarid‐Segal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofra Sarid‐Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofra Sarid‐Segal. The network helps show where Ofra Sarid‐Segal may publish in the future.

Co-authorship network of co-authors of Ofra Sarid‐Segal

This figure shows the co-authorship network connecting the top 25 collaborators of Ofra Sarid‐Segal. A scholar is included among the top collaborators of Ofra Sarid‐Segal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofra Sarid‐Segal. Ofra Sarid‐Segal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Knapp, Clifford M., Domenic A. Ciraulo, Ofra Sarid‐Segal, et al.. (2014). Zonisamide, Topiramate, and Levetiracetam. Journal of Clinical Psychopharmacology. 35(1). 34–42. 56 indexed citations
3.
Litten, Raye Z., Megan L. Ryan, Joanne B. Fertig, et al.. (2013). A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence. Journal of Addiction Medicine. 7(4). 277–286. 216 indexed citations
4.
Afshar, Maryam, et al.. (2012). The Efficacy of Mirtazapine in the Treatment of Cocaine Dependence with Comorbid Depression. The American Journal of Drug and Alcohol Abuse. 38(2). 181–186. 38 indexed citations
5.
Sarid‐Segal, Ofra, Clifford M. Knapp, Mark A. Richardson, et al.. (2009). The Anticonvulsant Zonisamide Reduces Ethanol Self-Administration by Risky Drinkers. The American Journal of Drug and Alcohol Abuse. 35(5). 316–319. 22 indexed citations
6.
Sarid‐Segal, Ofra, et al.. (2008). The Effects of Levetiracetam on Alcohol Consumption in Alcohol-Dependent Subjects: An Open Label Study. The American Journal of Drug and Alcohol Abuse. 34(4). 441–447. 24 indexed citations
7.
Streeter, Chris C., Devin B. Terhune, Theodore H. Whitfield, et al.. (2007). Performance on the Stroop Predicts Treatment Compliance in Cocaine-Dependent Individuals. Neuropsychopharmacology. 33(4). 827–836. 157 indexed citations
8.
Sim, Minyoung, In Kyoon Lyoo, Chris C. Streeter, et al.. (2007). Cerebellar Gray Matter Volume Correlates with Duration of Cocaine Use in Cocaine-Dependent Subjects. Neuropsychopharmacology. 32(10). 2229–2237. 145 indexed citations
9.
Winhusen, Theresa, Eugene Somoza, Ofra Sarid‐Segal, et al.. (2007). A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence. Drug and Alcohol Dependence. 91(2-3). 205–212. 24 indexed citations
10.
Ciraulo, Domenic A., Robert Hitzemann, Eugene Somoza, et al.. (2006). Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose‐Escalation Trials. The Journal of Clinical Pharmacology. 46(2). 179–192. 47 indexed citations
11.
Ciraulo, Domenic A., Clifford M. Knapp, John Rotrosen, et al.. (2005). Nefazodone treatment of cocaine dependence with comorbid depressive symptoms. Addiction. 100(s1). 23–31. 23 indexed citations
12.
Streeter, Chris C., John Hennen, Yong Ke, et al.. (2005). Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment. Psychopharmacology. 182(4). 516–526. 25 indexed citations
13.
Ciraulo, Domenic A., Ofra Sarid‐Segal, Clifford M. Knapp, et al.. (2005). Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence. Addiction. 100(s1). 12–22. 45 indexed citations
14.
Ke, Yong, Chris C. Streeter, Ofra Sarid‐Segal, et al.. (2004). Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Research Neuroimaging. 130(3). 283–293. 67 indexed citations
15.
Lyoo, In Kyoon, Chris C. Streeter, Ho Kyu Lee, et al.. (2004). White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Research Neuroimaging. 131(2). 135–145. 82 indexed citations
16.
Johnson, Bankole A., Stephanie S. O’Malley, Domenic A. Ciraulo, et al.. (2003). . Journal of Clinical Psychopharmacology. 23(3). 281–293. 1 indexed citations
17.
Johnson, Bankole A., Stephanie S. O’Malley, Domenic A. Ciraulo, et al.. (2003). Dose-Ranging Kinetics and Behavioral Pharmacology of Naltrexone and Acamprosate, Both Alone and Combined, in Alcohol-Dependent Subjects. Journal of Clinical Psychopharmacology. 23(3). 281–293. 55 indexed citations
18.
Sarid‐Segal, Ofra, et al.. (2000). Decreased EEG Sensitivity to Alprazolam in Subjects with a Parental History of Alcoholism. The Journal of Clinical Pharmacology. 40(1). 84–90. 3 indexed citations
19.
Ciraulo, Domenic A., Jamie Barnhill, Ofra Sarid‐Segal, et al.. (1997). Alterations in Pharmacodynamics of Anxiolytics in Abstinent Alcoholic Men: Subjective Responses, Abuse Liability, and Electroencephalographic Effects of Alprazolam, Diazepam, and Buspirone. The Journal of Clinical Pharmacology. 37(1). 64–73. 21 indexed citations
20.
Goff, Donald, et al.. (1993). A placebo-controlled trial of selegiline (l-deprenyl) in the treatment of tardive dyskinesia. Biological Psychiatry. 33(10). 700–706. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026